Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, on what dates since July 2014 he has discussed with NHS England the use of off-patent drugs for new indications; and if he will make a statement.

Departmental officials have had a number of discussions with NHS England which have included this issue, as well as discussions with other stakeholders. We are committed to supporting clinicians in incorporating the most up to date and robust evidence into patient care.